ScreenerHero

PHGE Tessera Defense and Homeland Security Inc.

Partial data
AMEX · US · Healthcare · Biotechnology · thlsq.ai
0.7060USD-1.94%Mkt Cap: 5.00M $P/E: —

Tessera Defense and Homeland Security Inc. develops and provides defense, homeland security, and critical infrastructure technologies. The company develops threat detection technology for defense and security application…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap5.00M USD
Enterprise Value15.95M USD
Revenue (TTM)332.00K USD
Gross Profit97.00K USD
Net Income (TTM)-36.20M USD
Revenue/Share0.80 USD
Last Price0.7060 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees20
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.03
PEG—
EV/EBITDA-0.80
EV/Revenue48.04
P/S15.05
P/B0.54
EPS (TTM)-153.23
EPS (Forward)-60.10
52W Range
0.11905% of range12.29
52W High12.29 USD
52W Low0.1190 USD
Profitability
Gross Margin29.22%
Oper. Margin-1630.72%
EBITDA Margin0.00%
Profit Margin0.00%
ROE2780.26%
ROA-625.96%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-26.39M USD
CapEx (TTM)2.00K USD
FCF Margin-1217.96%
FCF Yield-80.95%
Net Debt793.00K USD
Net Debt/EBITDA-0.04
Balance Sheet
Debt/Equity-1.10
Current Ratio0.24
Quick Ratio0.09
Book Value/Sh3.46 USD
Cash/Share0.21 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateSep 9, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.2.70M
Float2.44M
Insiders—
Institutions—
Technical
SMA 501.584 (-55.4%)
SMA 20020.50 (-96.6%)
Beta1.34
S&P 52W Chg14.29%
Avg Vol (30d)1.62M
Avg Vol (10d)1.33M
Technical Indicators
RSI (14)55.5
MACD0.1937
MACD Signal0.1311
MACD Hist.+0.0625
BB Upper1.465 USD
BB Middle0.4429 USD
BB Lower-0.5793 USD
BB Width461.63%
ATR (14)0.2109 USD
Vol Ratio (20d)0.31x